Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoru Murata

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Ras activation in T cells determines the development of antigen-induced airway hyperresponsiveness and eosinophilic inflammationYouichi Shibata, Tohru Kamata, Motoko Kimura, et al.
Journal of Medicinal Chemistry|May 17, 2012
Synthesis and structure-activity relationships of pyrazolo[1,5-a]pyridine derivatives: potent and orally active antagonists of corticotropin-releasing factor 1 receptorYoshinori Takahashi, Shigeki Hibi, Yorihisa Hoshino, et al.
Journal of Insect Physiology|July 5, 2014
Ionic channel mechanisms mediating the intrinsic excitability of Kenyon cells in the mushroom body of the cricket brainShigeki Inoue, Kaoru Murata, Aiko Tanaka, et al.
Scientific Reports|July 22, 2017
Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate ProdrugYoshimasa Tanaka, Masashi Iwasaki, Kaoru Murata-Hirai, et al.
Cancer Science|February 8, 2013
Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acidAtif S M Idrees, Tomoharu Sugie, Chiyomi Inoue, et al.
Bioorganic & Medicinal Chemistry|October 16, 2012
Synthesis and structure-activity relationships of 8-substituted-2-aryl-5-alkylaminoquinolines: Potent, orally active corticotropin-releasing factor-1 receptor antagonistsKunitoshi Takeda, Taro Terauchi, Minako Hashizume, et al.
Journal of Medicinal Chemistry|September 14, 2012
Design, synthesis, and structure-activity relationships of novel pyrazolo[5,1-b]thiazole derivatives as potent and orally active corticotropin-releasing factor 1 receptor antagonistsYoshinori Takahashi, Minako Hashizume, Kogyoku Shin, et al.
International Immunology|July 29, 2003
CD69-null mice protected from arthritis induced with anti-type II collagen antibodiesKaoru Murata, Masamichi Inami, Akihiro Hasegawa, et al.
Cancer Science|December 31, 2017
Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrugYoshimasa Tanaka, Kaoru Murata-Hirai, Masashi Iwasaki, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Ras activation in T cells determines the development of antigen-induced airway hyperresponsiveness and eosinophilic inflammationYouichi Shibata, Tohru Kamata, Motoko Kimura, et al.
Journal of Medicinal Chemistry|May 17, 2012
Synthesis and structure-activity relationships of pyrazolo[1,5-a]pyridine derivatives: potent and orally active antagonists of corticotropin-releasing factor 1 receptorYoshinori Takahashi, Shigeki Hibi, Yorihisa Hoshino, et al.
Journal of Insect Physiology|July 5, 2014
Ionic channel mechanisms mediating the intrinsic excitability of Kenyon cells in the mushroom body of the cricket brainShigeki Inoue, Kaoru Murata, Aiko Tanaka, et al.
Scientific Reports|July 22, 2017
Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate ProdrugYoshimasa Tanaka, Masashi Iwasaki, Kaoru Murata-Hirai, et al.
Cancer Science|February 8, 2013
Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acidAtif S M Idrees, Tomoharu Sugie, Chiyomi Inoue, et al.
Bioorganic & Medicinal Chemistry|October 16, 2012
Synthesis and structure-activity relationships of 8-substituted-2-aryl-5-alkylaminoquinolines: Potent, orally active corticotropin-releasing factor-1 receptor antagonistsKunitoshi Takeda, Taro Terauchi, Minako Hashizume, et al.
Journal of Medicinal Chemistry|September 14, 2012
Design, synthesis, and structure-activity relationships of novel pyrazolo[5,1-b]thiazole derivatives as potent and orally active corticotropin-releasing factor 1 receptor antagonistsYoshinori Takahashi, Minako Hashizume, Kogyoku Shin, et al.
International Immunology|July 29, 2003
CD69-null mice protected from arthritis induced with anti-type II collagen antibodiesKaoru Murata, Masamichi Inami, Akihiro Hasegawa, et al.
Cancer Science|December 31, 2017
Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrugYoshimasa Tanaka, Kaoru Murata-Hirai, Masashi Iwasaki, et al.
Pageof 2